Skip to main content
OpenTrials
Completed

NCT Number: NCT00670995

Tobacco Zero: Interactive Tobacco Education for Teens

There have been a number of tobacco prevention programs developed and tested in the past few years, and some of the comprehensive programs have been promoted by the Office on Smoking and Health at the Centers for Disease Control (CDC). However, the use of these programs and integration into school-based curriculum has been lacking due to a number of factors. We are proposing to develop an interactive computer-based program for tobacco prevention aimed at middle school students. The CD-ROM is designed to be an adjunct to the existing health education curriculum provided for 6th through 8th grade students.

Completed

Looking for future studies?

Notify Me

Key information

Age range

11 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Deschutes Research Inc

Eugene, Oregon, 97401, United States

About this study

The CD-ROM is based upon our Phase I prototype program entitled Tobacco World in which students are presented with a video arcade interface that offers them random access to several game-like activities in which they learn about tobacco and the negative health effects associated with tobacco use. We will expand the menu of options to include more complex activities and entertaining games.

The Phase II program will deliver engaging media to educate students about the risks of tobacco and peer and industry influences on their decisions regarding tobacco. Games and activities will be designed to act on mechanisms shown to be effective in decreasing intentions to use tobacco through changing attitudes, social images, beliefs about short and long term physical consequences, perceptions of peers' social images, subjective norms, and perceived behavioral control. We will test individual components of the program with middle school students for effectiveness in changing mediating variables related to initiation and use of tobacco.

The final program will be evaluated in a randomized trial where middle schools in Oregon and New York will be assigned to either an established tobacco prevention curriculum, or to the usual tobacco curriculum plus the Tobacco World program. Students will be assessed at pre-, post- and 6-month follow-up to evaluate the impact of program use on intentions, and actual tobacco use.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Middle school students in 6th or 7th or 8th grade in Oregon and New York City whose parents have consented to have their child participate;
  • Middle school health education teachers in Oregon and New York City

Exclusion criteria

  • Students unable to understand English.

Treatment and study plan

Interactive Tobacco Education

Behavioral

Increase perceived behavioral control (self-efficacy) Decrease willingness to use tobacco Decrease intentions to use tobacco

Primary outcomes

  1. Increase perceived behavioral control (self-efficacy)

    Time frame: pre and post

Secondary outcomes

  1. Decrease willingness to use tobacco

    Time frame: pre and post

  2. Decrease intentions to use tobacco

    Time frame: pre and post

Sponsors and collaborators

Lead sponsor

Deschutes Research, Inc.

Other

Collaborators

  • Columbia University

Registry information

Official study title

Tobacco World: Interactive Tobacco Education for Teens

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
May 2, 2008
Registry last updated
Feb 17, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.